Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tg Therapeuticscmn (NQ: TGTX )

21.00 -0.23 (-1.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,545,482
Open 21.36
Bid (Size) 20.77 (5)
Ask (Size) 21.00 (1)
Prev. Close 21.23
Today's Range 20.94 - 21.50
52wk Range 6.460 - 23.12
Shares Outstanding 150,977,564
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
$1000 Invested In TG Therapeutics 5 Years Ago Would Be Worth This Much Today
Via Benzinga
In the world of growth stocks, NASDAQ:TGTX shines as a value proposition.
Looking for growth without the hefty price tag? Consider TG THERAPEUTICS INC (NASDAQ:TGTX). 
Via Chartmill

Performance

YTD
+23.24%
+23.24%
1 Month
+23.67%
+23.67%
3 Month
+52.39%
+52.39%
6 Month
+39.35%
+39.35%
1 Year
+0.24%
+0.24%

More News

Read More
"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker
Via The Motley Fool
Nasdaq 100 Overbought? Here’s What History Says About The Current Rally
Via Talk Markets
The Most Shorted Stocks in June: Hold, Short, or Squeeze?
Via MarketBeat
(TGTX) - Analyzing TG Therapeutics's Short Interest
Via Benzinga
Peering Into TG Therapeutics's Recent Short Interest
Via Benzinga
(TGTX) - Analyzing TG Therapeutics's Short Interest
Via Benzinga
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
Via FinancialNewsMedia
Exposures Product Safety
Why TG Therapeutics Stock Was Rocketing Higher This Week
Via The Motley Fool
TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Earnings Preview For TG Therapeutics
Via Benzinga
How Is The Market Feeling About TG Therapeutics?
Via Benzinga
Looking Into TG Therapeutics's Recent Short Interest
Via Benzinga
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
From FN Media Group LLC
Via GlobeNewswire
TG Therapeutics stock just rallied 30%: what happened?
Via Talk Markets
Powell Industries Posts Upbeat Results, Joins A10 Networks, Garmin, DuPont And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Is Multiple Sclerosis-Focused TG Therapeutics Stock Trading Higher Today?
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
TG Therapeutics Soars On In-Line Report; Is The Biotech Rally Buoying Shares?
Via Investor's Business Daily
Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 28, 2024
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Exciting Stocks Poised for Explosive Growth in Key Sectors
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.